Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-10-000032
Filing Date
2010-05-20
Accepted
2010-05-20 12:53:19
Documents
2
Period of Report
2010-05-20

Document Format Files

Seq Description Document Type Size
1 6K FORM form6-k.htm 6-K 24770
2 US GAAP NOTE Q1 2010 ex99.htm EX-99.1 71584
  Complete submission text file 0001129928-10-000032.txt   97777
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 10847242
SIC: 2834 Pharmaceutical Preparations